Related Experiment Video
Updated: Jul 18, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
Published on: June 7, 2019
Mutational analysis of Chk1, Chk2, Apaf1 and Rb1 in human malignant melanoma cell lines
Thilo Papp1, Annett Niemetz, Nils Dosdahl
1Department of Biological Sciences, Institute of Cell Biology and Biosystems Technology, University of Rostock, Albert Einstein Strasse 3, 18051 Rostock, Germany. thilo.papp@biologie.uni-rostock.de
Abstract:
Four tumour suppressor genes (Chk1, Chk2, Apaf1 and Rb1) in nine human malignant melanoma cell lines were screened for a loss of gene expression, point mutations and small deletions/insertions by cDNA-based DGGE/SCCP analysis. In two cell lines alterations of the investigated genes could be demonstrated. This result confirms our assumption of the participation of dysfunctional p53 inducer/effector genes in human melanoma aetiology. Furthermore, it points towards the probable principal role of diverse alternative p53-pathway disruption mechanisms in this highly therapy-resistant malignancy without affecting p53 itself. To our knowledge, this is the first CHK1/CHK2 mutation screening in human melanoma.
Insights
This study investigated tumor suppressor genes in melanoma cell lines, finding alterations in two lines. This suggests alternative p53 pathway disruptions contribute to melanoma development.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Malignant melanoma is a therapy-resistant cancer.
- The p53 pathway is crucial in cancer suppression.
- Dysfunctional p53 pathway genes may contribute to melanoma.
Purpose of the Study:
- To screen for alterations in four key tumor suppressor genes (Chk1, Chk2, Apaf1, Rb1) in human melanoma cell lines.
- To investigate the role of p53 inducer/effector genes in melanoma etiology.
- To explore alternative p53-pathway disruption mechanisms in melanoma.
Main Methods:
- cDNA-based Differential Gel Electrophoresis (DGGE) and Single-Strand Conformation Polymorphism (SCCP) analysis.
- Screening of Chk1, Chk2, Apaf1, and Rb1 genes for loss of expression, point mutations, and small deletions/insertions.
- Analysis of nine human malignant melanoma cell lines.
Main Results:
- Alterations in the investigated tumor suppressor genes were identified in two out of nine melanoma cell lines.
- The findings support the involvement of dysfunctional p53 inducer/effector genes in human melanoma.
- This study provides evidence for alternative mechanisms disrupting the p53 pathway in melanoma, independent of p53 mutations.
Conclusions:
- Dysfunctional p53 pathway genes play a role in human melanoma etiology.
- Alternative mechanisms disrupting the p53 pathway are likely important in melanoma.
- This is the first study to screen for CHK1/CHK2 mutations in human melanoma.
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle
The Ras Gene
Ras is a superfamily...

